President Joe Biden will not visit the Emergent BioSolutions’ lab in Baltimore this week.
It had originally been planned as an event with the CEOs of Johnson & Johnson and Merck on Tuesday. The meeting is now moved to Washington, D.C., according to the White House.
Emergent BioSolutions released this statement Monday morning in response:Merck is also manufacturing J&J’s vaccine, which received emergency use authorization late last month.
“The Administration is always welcome to visit our facilities. We applaud the work of the White House coronavirus task force to forge partnerships and expedite the vaccine production process. We remain focused on working around the clock to do our part in manufacturing the vaccines needed to beat this pandemic,”
Statement from Emergent BioSolutions ⬇️ @wjz pic.twitter.com/RuDfk6KdpL
They also released an updated statement related to a New York Times article published over the weekend criticizing the company.
The latest statement from Emergent BioSolutions @wjz pic.twitter.com/P7bXfa0WNE
— Mike Hellgren (@HellgrenWJZ) March 8, 2021
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.